Suppr超能文献

肿瘤体积对T1期声门癌患者局部控制和生存的影响:30年经验

Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.

作者信息

Reddy Sarada P, Hong Robert L, Nagda Suneel, Emami Bahman

机构信息

Loyola-Hines Department of Radiotherapy, Loyola University Chicago, Maywood, IL 60153, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1389-94. doi: 10.1016/j.ijrobp.2007.05.077. Epub 2007 Sep 14.

Abstract

PURPOSE

To evaluate the effect of tumor bulk on local control and survival of patients with T1 glottic cancer.

METHODS AND MATERIALS

Effects of tumor bulk, T-stage, anterior-commissure involvement, treatment duration, and fraction size were analyzed in 208 patients; 136 had small tumors and 72 had bulky tumors. Anterior-commissure was involved in 54 patients. Treatment duration ranged from 39 to 64 days and fraction size ranged from 1.8 to 2.0 Gy. Median follow-up was 5.1 years.

RESULTS

Five-year actuarial local control rates were 86.1% and 91.4% after radiotherapy and salvage laryngectomy. On univariate analysis, local control rates were 92.6% and 73.6% for small and bulky tumors (p = 0.03), 89.6% and 75.9% for patients without and with anterior-commissure involvement (p = 0.01), 92.6% and 75.6% when treatment duration was <or=50 days and >50 days (p = 0.04), and 90.2% and 76.4% with 2 Gy and 1.8 Gy (p = 0.02) per fraction. On multivariate analysis, tumor bulk was the only significant factor that affected local control (p = 0.007). Ultimate local control rates after salvage were 97.1% and 80.5% for patients with small and bulky tumors. Disease-free survival rates at 5 years for small and bulky tumors were 96.3% and 84.7% (p = 0.001). Median duration to recurrence for small tumors was 30 months as compared with 11 months for bulky tumors.

CONCLUSION

Tumor bulk is a highly significant prognostic factor for radiation control of T1 glottic cancer. Patients with bulky tumors had lower local control and disease-free survival rates and shorter duration to recurrence than those with small tumors.

摘要

目的

评估肿瘤大小对T1期声门癌患者局部控制率和生存率的影响。

方法和材料

分析了208例患者的肿瘤大小、T分期、前联合受累情况、治疗持续时间和分次剂量的影响;136例为小肿瘤患者,72例为大肿瘤患者。54例患者前联合受累。治疗持续时间为39至64天,分次剂量为1.8至2.0 Gy。中位随访时间为5.1年。

结果

放疗和挽救性喉切除术后5年精算局部控制率分别为86.1%和91.4%。单因素分析显示,小肿瘤和大肿瘤的局部控制率分别为92.6%和73.6%(p = 0.03),无前联合受累和有前联合受累患者的局部控制率分别为89.6%和75.9%(p = 0.01),治疗持续时间≤50天和>50天患者的局部控制率分别为92.6%和75.6%(p = 0.04),每次分次剂量为2 Gy和1.8 Gy患者的局部控制率分别为90.2%和76.4%(p = 0.02)。多因素分析显示,肿瘤大小是影响局部控制的唯一显著因素(p = 0.007)。小肿瘤和大肿瘤患者挽救治疗后的最终局部控制率分别为97.1%和80.5%。小肿瘤和大肿瘤患者5年无病生存率分别为96.3%和84.7%(p = 0.001)。小肿瘤复发的中位时间为30个月,而大肿瘤为11个月。

结论

肿瘤大小是T1期声门癌放射治疗控制的一个高度显著的预后因素。大肿瘤患者的局部控制率和无病生存率较低,复发时间比小肿瘤患者短。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验